Ken Bertsch, the executive director of the Council of Institutional Investors speaks with The Deal for its Activist Investing Today podcast about why he thinks 5% threshold poison pills are an 'extraordinary statement of weakness' on the part of the company adopting them. Bertsch also talks about virtual meeting shenanigans and universal proxy cards.
